Larry Friedrich

Larry Friedrich has a diverse work experience in the pharmaceutical industry. Larry is currently working as the Executive Director of Medical Affairs at AN2 Therapeutics since December 2022. Previously, from 2020 to 2022, they served as the Executive Director of Real World Evidence and Data Generation at Spero Therapeutics, where they were responsible for developing and implementing the data generation strategic plan.

Before that, from 2018 to 2020, Larry held the position of Senior Director of Medical Sciences at Paratek Pharmaceuticals. In this role, they developed and implemented the strategic data generation plan for Paratek Medical Affairs and was involved in various research programs and initiatives.

From 2015 to 2018, Larry worked as the Infectious Diseases Scientific Director at Merck Research Laboratories. Here, they provided research expertise for external investigators and coordinated research strategies internally.

Larry's earlier experience includes roles at Cubist Pharmaceuticals, where they worked from 2004 to 2015. As the Senior Director of External Research Medical Affairs, they managed operations and had fiscal oversight of all Medical Affairs sponsored study programs. Larry also served as the Clinical Scientific Director, where they interacted with key investigators and provided medical/scientific data for clinicians.

Overall, Larry Friedrich's work experience showcases their expertise in medical affairs, real-world evidence, data generation, and strategic planning in the pharmaceutical industry.

Larry Friedrich's education history includes a Bachelor of Science degree in Pharmacy from the University of Wisconsin-Madison. Larry has also pursued further studies at the Medical University of South Carolina, where they earned a Doctor of Pharmacy degree. No specific start or end years are provided for either of these educational experiences.